Elevation Oncology, Inc. Common stock

ELEV

...

ELEV: Elevation Oncology Inc is an oncology company focused on the development of targeted therapeutics for the treatment of cancer in genomically defined patient populations. Its lead program is focused on neuregulin-1, or NRG1, fusions, which are rare genomic alterations that have the potential to be therapeutically actionable through targeted HER3 inhibition.

Show ELEV Financials

All

Government

Consumer Interest

SEC Filings

ESG/Other

Congress Trading

Recent trades of ELEV by members of U.S. Congress

No Congress Trading data for this ticker

Congress Trading Dashboard

Whale Activity

Recently reported changes by institutional investors

Insider Trading

Quarterly net insider trading by ELEV's directors and management

No recent Insider Trading for this ticker

Insider Trading Dashboard

Corporate Lobbying

Government lobbying spending instances

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard

U.S. Patents

New patents grants

No new patents for this ticker

U.S. Patents Dashboard

Government Contracts

Federal grants, loans, and purchases

No Government Contracts for this ticker

Government Contracts Dashboard

Twitter

Followers on ELEV's company Twitter account

WallStreetBets

Number of mentions of ELEV in WallStreetBets Daily Discussion

ELEV News

Recent insights relating to ELEV

CNBC Recommendations

Recent picks made for ELEV stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in ELEV

Corporate Flights

Flights by private jets registered to ELEV